Proposed Data Collection Submitted for Public Comment and Recommendations, 457-458 [2019-00276]

Download as PDF 457 Federal Register / Vol. 84, No. 19 / Tuesday, January 29, 2019 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Type of respondents Form name Hospital CEO/CFO .......................................... Annual Hospital Interview .............................. Jeffrey M. Zirger, Acting Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2019–00214 Filed 1–28–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–19–1170; Docket No. CDC–2018– 0113] Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the data collection project titled ‘‘Canine leptospirosis surveillance in Puerto Rico.’’ This surveillance project aims to characterize the epidemiology of canine leptospirosis, assess the applicability of canine Leptospira vaccines used in Puerto Rico, and determine potential rodent, livestock, and wildlife reservoirs for leptospirosis. Findings from the study will be used to develop recommendations for the prevention of leptospirosis in dogs, focus human surveillance efforts, and guide further investigations on leptospirosis in Puerto Rico. DATES: CDC must receive written comments on or before April 1, 2019. ADDRESSES: You may submit comments, identified by Docket No. CDC–2018– 0113 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. SUMMARY: VerDate Sep<11>2014 16:14 Jan 28, 2019 Jkt 247001 598 Average burden per response (in hours) 1 2 • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to Regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. 5. Assess information collection costs. To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS– D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. Canine Leptospirosis Surveillance in Puerto Rico (OMB Control No. 0920– 1170 Exp. Date 03/31/2019)— Revision—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). FOR FURTHER INFORMATION CONTACT: Proposed Data Collection Submitted for Public Comment and Recommendations Number of responses per respondent Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; SUPPLEMENTARY INFORMATION: PO 00000 Frm 00007 Fmt 4703 Sfmt 4703 Proposed Project Background and Brief Description The Centers for Disease Control and Prevention (CDC) Bacterial Special Pathogens Branch (BSPB) requests for approval of revisions to existing data collection tools used in active surveillance for canine leptospirosis in Puerto Rico. The methods for data collection have not changed. Active surveillance allows for the collection of prospective data on acute cases to determine the incidence and distribution of leptospirosis in dogs, assess risk factors for infection, characterize circulating Leptospira serovars and species, assess applicability of vaccines currently in use based on serovar determination, and assess rodent, livestock, and wildlife reservoirs of leptospirosis based on infecting serovars found in dogs. Findings from this study will aid in the development of evidence-based, targeted interventions for the prevention of canine leptospirosis, be used to focus human leptospirosis surveillance efforts, and guide future investigations on leptospirosis in humans and animals in Puerto Rico. The information collection for which approval sought is in accordance with BSPB’s mission to prevent illness, disability, or death caused by bacterial zoonotic diseases through surveillance, epidemic investigations, epidemiologic and laboratory research, training and E:\FR\FM\29JAN1.SGM 29JAN1 458 Federal Register / Vol. 84, No. 19 / Tuesday, January 29, 2019 / Notices public education. Authorizing Legislation comes from Section 301 of the Public Health Service Act (42 U.S.C. 241). Successful execution of BSPB’s public health mission requires data collection activities in collaboration with the state health department in Puerto Rico and with local veterinary clinics and animal shelters participating in the study. These activities include collecting information about dogs that meet the study case definition for a suspect case of leptospirosis seen at participating veterinary clinics and shelters. Participating veterinarians and their veterinary staff collect information by interviewing the dog owner (shelters are an exception as dog will not have an history, clinical signs and symptoms, laboratory results, and clinical outcome. Approval of this revision ICR will allow BSPB to continue to collect information which can help inform animal public health and will help contribute to a One Health understanding of leptospirosis in Puerto Rico. BSPB estimates involvement of at least 411 respondents (a minimum 385 from the general public and 26 veterinarians and their veterinary staff) and estimates a total of 168 hours of burden for research activities each year. The collected information will not impose a cost burden on the respondents beyond that associated with their time to provide the required data. owner) and reviewing medical and administrative records, as necessary. Basic information about the participating sites will also be collected for study management and to enhance data analysis. Information will be collected using paper forms and provided in Spanish. Staff at participating sites find it easier to complete a paper copy when abstracting medical record information and interviewing owners for information about their dog’s risk factors and symptoms. Study coordinators will enter collected data into an electronic database. The types of information collected include information about the dog’s signalment, location of residence, environmental risk factors, vaccination ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden (in hours) Type of respondents Form name Veterinarians or veterinary staff ........ 26 1 5/60 2 Veterinarians or veterinary staff ........ Veterinarians or veterinary staff ........ Dog owners (general public) ............. Enrollment Questionnaire (Attachment C). Log Sheet (Attachment D) ............... Case Questionnaire (Attachment E) Case Questionnaire (Attachment E) 26 26 624 24 24 1 1/60 10/60 5/60 10 104 52 Total ........................................... ........................................................... ........................ ........................ ........................ 168 Jeffrey M. Zirger, Acting Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2019–00276 Filed 1–28–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Sep<11>2014 16:14 Jan 28, 2019 Jkt 247001 Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group; Cellular and Molecular Biology of Neurodegeneration Study Section. Date: January 31–February 1, 2019. Time: 8:30 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Catamaran Hotel, 3999 Mission Boulevard, San Diego, CA 92109. Contact Person: Laurent Taupenot, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4183, MSC 7850, Bethesda, MD 20892, 301–435– 1203, taupenol@csr.nih.gov. This meeting notice is being published less than 15 days in advance of the meeting due to the partial Government shutdown of December 2018. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: January 18, 2019. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–00203 Filed 1–28–19; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00008 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Cancer Advisory Board. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https:// videocast.nih.gov). The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, E:\FR\FM\29JAN1.SGM 29JAN1

Agencies

[Federal Register Volume 84, Number 19 (Tuesday, January 29, 2019)]
[Notices]
[Pages 457-458]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00276]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-19-1170; Docket No. CDC-2018-0113]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on the data 
collection project titled ``Canine leptospirosis surveillance in Puerto 
Rico.'' This surveillance project aims to characterize the epidemiology 
of canine leptospirosis, assess the applicability of canine Leptospira 
vaccines used in Puerto Rico, and determine potential rodent, 
livestock, and wildlife reservoirs for leptospirosis. Findings from the 
study will be used to develop recommendations for the prevention of 
leptospirosis in dogs, focus human surveillance efforts, and guide 
further investigations on leptospirosis in Puerto Rico.

DATES: CDC must receive written comments on or before April 1, 2019.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2018-
0113 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
omb@cdc.gov.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    Canine Leptospirosis Surveillance in Puerto Rico (OMB Control No. 
0920-1170 Exp. Date 03/31/2019)--Revision--National Center for Emerging 
and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control 
and Prevention (CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention (CDC) Bacterial 
Special Pathogens Branch (BSPB) requests for approval of revisions to 
existing data collection tools used in active surveillance for canine 
leptospirosis in Puerto Rico. The methods for data collection have not 
changed.
    Active surveillance allows for the collection of prospective data 
on acute cases to determine the incidence and distribution of 
leptospirosis in dogs, assess risk factors for infection, characterize 
circulating Leptospira serovars and species, assess applicability of 
vaccines currently in use based on serovar determination, and assess 
rodent, livestock, and wildlife reservoirs of leptospirosis based on 
infecting serovars found in dogs. Findings from this study will aid in 
the development of evidence-based, targeted interventions for the 
prevention of canine leptospirosis, be used to focus human 
leptospirosis surveillance efforts, and guide future investigations on 
leptospirosis in humans and animals in Puerto Rico.
    The information collection for which approval sought is in 
accordance with BSPB's mission to prevent illness, disability, or death 
caused by bacterial zoonotic diseases through surveillance, epidemic 
investigations, epidemiologic and laboratory research, training and

[[Page 458]]

public education. Authorizing Legislation comes from Section 301 of the 
Public Health Service Act (42 U.S.C. 241). Successful execution of 
BSPB's public health mission requires data collection activities in 
collaboration with the state health department in Puerto Rico and with 
local veterinary clinics and animal shelters participating in the 
study.
    These activities include collecting information about dogs that 
meet the study case definition for a suspect case of leptospirosis seen 
at participating veterinary clinics and shelters. Participating 
veterinarians and their veterinary staff collect information by 
interviewing the dog owner (shelters are an exception as dog will not 
have an owner) and reviewing medical and administrative records, as 
necessary. Basic information about the participating sites will also be 
collected for study management and to enhance data analysis.
    Information will be collected using paper forms and provided in 
Spanish. Staff at participating sites find it easier to complete a 
paper copy when abstracting medical record information and interviewing 
owners for information about their dog's risk factors and symptoms. 
Study coordinators will enter collected data into an electronic 
database.
    The types of information collected include information about the 
dog's signalment, location of residence, environmental risk factors, 
vaccination history, clinical signs and symptoms, laboratory results, 
and clinical outcome. Approval of this revision ICR will allow BSPB to 
continue to collect information which can help inform animal public 
health and will help contribute to a One Health understanding of 
leptospirosis in Puerto Rico.
    BSPB estimates involvement of at least 411 respondents (a minimum 
385 from the general public and 26 veterinarians and their veterinary 
staff) and estimates a total of 168 hours of burden for research 
activities each year. The collected information will not impose a cost 
burden on the respondents beyond that associated with their time to 
provide the required data.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Veterinarians or veterinary     Enrollment                    26               1            5/60               2
 staff.                          Questionnaire
                                 (Attachment C).
Veterinarians or veterinary     Log Sheet                     26              24            1/60              10
 staff.                          (Attachment D).
Veterinarians or veterinary     Case                          26              24           10/60             104
 staff.                          Questionnaire
                                 (Attachment E).
Dog owners (general public)...  Case                         624               1            5/60              52
                                 Questionnaire
                                 (Attachment E).
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             168
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2019-00276 Filed 1-28-19; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.